|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
53,543,000 |
Market
Cap: |
10.88(B) |
Last
Volume: |
418,372 |
Avg
Vol: |
474,971 |
52
Week Range: |
$164.52 - $273.43 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 400 MIDCAP |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 456 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Charles River Laboratories International is a contract research organization. Co. has a laboratory animal medicine and science to develop a portfolio of discovery and safety assessment services. Co.'s segments include: Research Models and Services, which supplies research models to the drug development industry; Discovery and Safety Assessment (DSA), which provides DSA services, including in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development; Manufacturing Support, which ensure the safe production and release of products manufactured by Co.'s clients.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
7,942 |
11,192 |
Total Buy Value |
$0 |
$0 |
$1,447,725 |
$2,162,353 |
Total People Bought |
0 |
0 |
3 |
3 |
Total Buy Transactions |
0 |
0 |
3 |
5 |
Total Shares Sold |
1,636 |
25,558 |
49,996 |
92,833 |
Total Sell Value |
$374,194 |
$6,377,856 |
$11,292,577 |
$21,658,880 |
Total People Sold |
2 |
6 |
6 |
8 |
Total Sell Transactions |
2 |
10 |
16 |
28 |
End Date |
2024-03-31 |
2023-12-29 |
2023-06-30 |
2022-06-30 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Smith David Ross |
Corporate Executive VP & CFO |
|
2017-08-14 |
4/A |
S |
$97.86 |
$127,508 |
D/D |
(1,303) |
15,310 |
|
- |
|
Smith David Ross |
Corporate Executive VP & CFO |
|
2017-08-14 |
4 |
AS |
$37.86 |
$171,228 |
D/D |
(2,552) |
11,671 |
|
- |
|
Smith David Ross |
Corporate Executive VP & CFO |
|
2017-08-14 |
4 |
OE |
$76.12 |
$95,074 |
D/D |
1,249 |
12,920 |
|
- |
|
Smith David Ross |
Corporate Executive VP & CFO |
|
2017-08-12 |
4 |
D |
$97.97 |
$27,823 |
D/D |
(284) |
12,974 |
|
- |
|
Mackay Martin |
Director |
|
2017-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,782 |
2,782 |
|
- |
|
Massaro George |
Director |
|
2017-07-17 |
4 |
AS |
$101.33 |
$20,276 |
D/D |
(200) |
14,701 |
|
- |
|
Massaro George |
Director |
|
2017-07-17 |
4 |
AS |
$100.26 |
$386,103 |
D/D |
(3,830) |
14,901 |
|
- |
|
Massaro George |
Director |
|
2017-07-17 |
4 |
OE |
$43.39 |
$174,862 |
D/D |
4,030 |
18,731 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2017-07-10 |
4 |
AS |
$99.92 |
$50,008 |
D/D |
(500) |
336,178 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2017-07-10 |
4 |
AS |
$99.19 |
$568,011 |
D/D |
(5,720) |
336,678 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2017-07-10 |
4 |
AS |
$99.00 |
$917,818 |
D/D |
(9,264) |
342,398 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2017-07-10 |
4 |
AS |
$98.76 |
$941,337 |
D/D |
(9,516) |
351,662 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2017-06-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,162 |
322,766 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2017-06-22 |
4 |
AS |
$100.00 |
$4,315,400 |
D/D |
(43,154) |
361,178 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2017-06-22 |
4 |
OE |
$76.67 |
$3,308,617 |
D/D |
43,154 |
404,332 |
|
- |
|
Molho Davide |
Corporate Executive VP |
|
2017-06-22 |
4 |
AS |
$100.00 |
$1,094,800 |
D/D |
(10,948) |
16,549 |
|
- |
|
Molho Davide |
Corporate Executive VP |
|
2017-06-22 |
4 |
OE |
$59.41 |
$650,421 |
D/D |
10,948 |
27,497 |
|
- |
|
Smith David Ross |
Corporate Executive VP & CFO |
|
2017-06-08 |
4 |
AS |
$95.00 |
$89,775 |
D/D |
(945) |
13,258 |
|
- |
|
Smith David Ross |
Corporate Executive VP & CFO |
|
2017-06-08 |
4 |
OE |
$51.45 |
$48,620 |
D/D |
945 |
14,203 |
|
- |
|
Molho Davide |
Corporate Executive VP |
|
2017-05-26 |
4 |
S |
$92.74 |
$1,019,022 |
D/D |
(10,976) |
16,549 |
|
- |
|
Molho Davide |
Corporate Executive VP |
|
2017-05-26 |
4 |
OE |
$40.40 |
$547,491 |
D/D |
10,976 |
22,023 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2017-05-25 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,500 |
361,178 |
|
- |
|
Thompson Craig B. |
Director |
|
2017-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
3,229 |
14,929 |
|
- |
|
Kochevar Deborah Turner |
Director |
|
2017-05-12 |
4 |
S |
$87.81 |
$621,640 |
D/D |
(7,070) |
8,786 |
|
- |
|
Kochevar Deborah Turner |
Director |
|
2017-05-12 |
4 |
OE |
$70.29 |
$220,711 |
D/D |
3,140 |
15,856 |
|
- |
|
1200 Records found
|
|
Page 33 of 48 |
|
|